To further support this, in a group of 109 patients with normalized CRP, functional improvement persisted unless CRP levels rose again, concluding that CRP suppression is associated with improved function and that elevated CRP can serve as a useful short-term predictor of functional outcomes and a therapeutic guide in early RA [12]. This evidence concerns the gene CRP and rheumatoid arthritis.